Idbiologics Inc.
Nashville, TN
- UEI
- JMM8XMM89MQ5
- CAGE
- 7ZPE6
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 2101 20th Ave S, Nashville, TN 37212, USA
- Website
- idbiologics.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $0 |
| FY2023 | $113,583 |
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Pcmid sbir topic 85 | National Institute of Allergy and Infectious Diseases (NIH) | $1,911,648 |
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Mapp Biopharmaceutical, Inc. | San Diego, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| VIR Biotechnology, Inc. | San Francisco, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Inhalon Biopharma, Inc. | Morrisville, NC | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Antagen Biosciences Inc. | Canton, MA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Centivax, Inc. | South San Francisco, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Idbiologics Inc. is a for-profit manufacturer that specializes in discovering and developing human monoclonal antibodies to prevent, treat, and cure infectious diseases. Through its innovative antibody platform, the company provides biopharmaceutical research and production services to federal agencies.
As a prime contractor, Idbiologics has been awarded a $1.9 million definitive contract by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to conduct biomedical research related to infectious diseases under the Small Business Innovation Research program. This fixed price contract has a total small business set aside designation and involves research activities taking place over a 4-year period in Nashville, TN.
Additionally, Idbiologics has received federal grants from the National Institutes of Health and Defense Health Agency to develop monoclonal antibodies targeting respiratory syncytial virus, Zika virus, and seasonal influenza. These project grants provide between $270,000 to $3.1 million in assistance funding to support Idbiologics' research and development programs related to infectious disease treatments and preventatives.
Quick answers
Is Idbiologics Inc. registered in SAM.gov?
Yes. Idbiologics Inc.'s SAM.gov registration is active through March 4, 2027.
How much has Idbiologics Inc. received in federal contracts?
Federal contracts obligated $113,583 to Idbiologics Inc. in fiscal years 2023 through 2027.
What is Idbiologics Inc.'s most recent federal award?
Idbiologics Inc.'s most recent federal contract award is Pcmid sbir topic 85 (75N93020C00027), from National Institute of Allergy and Infectious Diseases (NIH), on September 1, 2020.
On GovTribe
See Idbiologics Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors